24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this crossover 24-hour Intraocular Pressure (IOP) trial is to
compare the control obtained after 3 months of therapy with the bimatoprost/timolol fixed
combination (BTFC, Ganfort) given once in the evening (20:00) versus latanoprost (Xalatan)
administered once in the evening (20:00) in newly-diagnosed patients with exfoliation
syndrome (XFS) and ocular hypertension, or exfoliative glaucoma (XFG) previously untreated
and IOP greater than 29 mm Hg.